1
|
Belcaro G, Cesarone MR, Ledda A, Scipione C, Scipione V, Corsi M, Cox D, Cotellese R, Feragalli B. Altitude trekking and Robuvit®: fatigue prevention and recovery. Minerva Med 2024; 115:83-84. [PMID: 37534833 DOI: 10.23736/s0026-4806.23.08677-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/04/2023]
Affiliation(s)
| | | | | | | | | | | | - David Cox
- Irvine3 Labs Institute, Pescara, Italy
| | - Roberto Cotellese
- Department of Medical, Oral and Biotechnological Sciences, D'Annunzio University Pescara-Chieti, Chieti, Italy
| | - Beatrice Feragalli
- Department of Medical, Oral and Biotechnological Sciences, D'Annunzio University Pescara-Chieti, Chieti, Italy
| |
Collapse
|
2
|
Hu S, Belcaro G, Hosoi M, Cesarone MR, Scipione V, Scipione C, Dugall M, Feragalli B, Cotellese R. Prevention of early lymphatic disease in women with Robuvit®: a new supplementary solution? Panminerva Med 2023; 65:91-92. [PMID: 36178110 DOI: 10.23736/s0031-0808.22.04754-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Shuh Hu
- Irvine3 Labs, Department SMOBiotec, G. D'Annunzio University, Chieti-Pescara University, Chieti, Chieti-Pescara, Italy.,IA-PSS: International Agency for Pharma-Standard Supplement, Pescara, Chieti-Pescara, Italy
| | - Gianni Belcaro
- Irvine3 Labs, Department SMOBiotec, G. D'Annunzio University, Chieti-Pescara University, Chieti, Chieti-Pescara, Italy - .,IA-PSS: International Agency for Pharma-Standard Supplement, Pescara, Chieti-Pescara, Italy
| | - Morio Hosoi
- Irvine3 Labs, Department SMOBiotec, G. D'Annunzio University, Chieti-Pescara University, Chieti, Chieti-Pescara, Italy.,IA-PSS: International Agency for Pharma-Standard Supplement, Pescara, Chieti-Pescara, Italy
| | - Maria R Cesarone
- Irvine3 Labs, Department SMOBiotec, G. D'Annunzio University, Chieti-Pescara University, Chieti, Chieti-Pescara, Italy.,IA-PSS: International Agency for Pharma-Standard Supplement, Pescara, Chieti-Pescara, Italy
| | - Valeria Scipione
- Irvine3 Labs, Department SMOBiotec, G. D'Annunzio University, Chieti-Pescara University, Chieti, Chieti-Pescara, Italy.,IA-PSS: International Agency for Pharma-Standard Supplement, Pescara, Chieti-Pescara, Italy
| | - Claudia Scipione
- Irvine3 Labs, Department SMOBiotec, G. D'Annunzio University, Chieti-Pescara University, Chieti, Chieti-Pescara, Italy.,IA-PSS: International Agency for Pharma-Standard Supplement, Pescara, Chieti-Pescara, Italy
| | - Mark Dugall
- Irvine3 Labs, Department SMOBiotec, G. D'Annunzio University, Chieti-Pescara University, Chieti, Chieti-Pescara, Italy.,IA-PSS: International Agency for Pharma-Standard Supplement, Pescara, Chieti-Pescara, Italy
| | - Beatrice Feragalli
- Irvine3 Labs, Department SMOBiotec, G. D'Annunzio University, Chieti-Pescara University, Chieti, Chieti-Pescara, Italy.,IA-PSS: International Agency for Pharma-Standard Supplement, Pescara, Chieti-Pescara, Italy
| | - Roberto Cotellese
- Irvine3 Labs, Department SMOBiotec, G. D'Annunzio University, Chieti-Pescara University, Chieti, Chieti-Pescara, Italy.,IA-PSS: International Agency for Pharma-Standard Supplement, Pescara, Chieti-Pescara, Italy
| |
Collapse
|
3
|
Potential Use of Quercus dalechampii Ten. and Q. frainetto Ten. Barks Extracts as Antimicrobial, Enzyme Inhibitory, Antioxidant and Cytotoxic Agents. Pharmaceutics 2023; 15:pharmaceutics15020343. [PMID: 36839665 PMCID: PMC9965348 DOI: 10.3390/pharmaceutics15020343] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2022] [Revised: 01/08/2023] [Accepted: 01/16/2023] [Indexed: 01/22/2023] Open
Abstract
The bark resulted as a by-product after different Quercus sp. processing is a valuable alternative source of phenolic compounds (mainly tannins). Hence, the focus of the present work was to obtain eight extracts from the rhytidome of the less-studied Q. dalechampii and Q. frainetto and characterize them in terms of chemical and bioactive profiles. Ultrasound and microwave-assisted extraction methods were used for the preparation of the extracts. Total phenolic and tannin contents were assessed through classic spectrophotometric methods, while several individual phenolic compounds were identified and quantified using UPLC-PDA. Antioxidant, enzyme-inhibitory, antibacterial, and cytotoxic activities were tested using in vitro assays; additionally being evaluated was the ability of the extracts to inhibit the adherence of MRSA to suture wires. The UPLC analysis confirmed the presence of gallic acid, catechin, taxifolin, vanillic acid, epicatechin, and caffeic acid. The results showed that tested extracts were able to exert cytotoxic effects, at 6% and 3% concentrations, on confluent cells. The tested solutions inhibit α-glucosidase activity and the antibacterial potential suggested a mild to moderate effect against the Gram-positive strains. Overall, the obtained results revealed rich phenolic and tannin contents for the extracts obtained from both species through microwave-assisted extraction, probably responsible for their mild antibacterial and cytotoxic effects.
Collapse
|
4
|
Häsler Gunnarsdottir S, Sommerauer L, Schnabel T, Oostingh GJ, Schuster A. Antioxidative and Antimicrobial Evaluation of Bark Extracts from Common European Trees in Light of Dermal Applications. Antibiotics (Basel) 2023; 12:antibiotics12010130. [PMID: 36671331 PMCID: PMC9854852 DOI: 10.3390/antibiotics12010130] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2022] [Revised: 01/03/2023] [Accepted: 01/04/2023] [Indexed: 01/12/2023] Open
Abstract
Plant species have developed effective defense strategies for colonizing diverse habitats and protecting themselves from numerous attacks from a wide range of organisms, including insects, vertebrates, fungi, and bacteria. The bark of trees in particular constitutes a number of components that protect against unwanted intruders. This review focuses on the antioxidative, dermal immunomodulatory, and antimicrobial properties of bark extracts from European common temperate trees in light of various skin pathogens, wound healing, and the maintenance of skin health. The sustainability aspect, achieved by utilizing the bark, which is considered a byproduct in the forest industry, is addressed, as are various extraction methods applied to retrieve extracts from bark.
Collapse
Affiliation(s)
| | - Lukas Sommerauer
- Department of Forest Products Technology & Timber Constructions, Salzburg University of Applied Sciences, Markt 136a, 5431 Kuchl, Austria
- Salzburg Center for Smart Materials, c/o Department of Chemistry and Physics of Materials, Paris Lodron University of Salzburg, Jakob-Haringer-Straße 2a, 5020 Salzburg, Austria
- Department of Material Sciences and Process Engineering, Institute of Physics and Materials Science, University of Natural Resources and Life Sciences, Peter-Jordan-Straße 82, 1190 Vienna, Austria
| | - Thomas Schnabel
- Department of Forest Products Technology & Timber Constructions, Salzburg University of Applied Sciences, Markt 136a, 5431 Kuchl, Austria
- Faculty of Furniture Design and Wood Engineering, Transilvania University of Brasov, B-dul. Eroilor nr. 29, 500036 Brasov, Romania
| | - Gertie Janneke Oostingh
- Biomedical Sciences, Salzburg University of Applied Sciences, Urstein Sued 1, 5412 Puch, Austria
| | - Anja Schuster
- Biomedical Sciences, Salzburg University of Applied Sciences, Urstein Sued 1, 5412 Puch, Austria
- Correspondence:
| |
Collapse
|
5
|
Belcaro G, Cox DM, Cesarone MR, Gizzi G, Pellegrini L, Scipione C, Scipione V, Dugall M, Hu S, Corsi M, Feragalli B, Cotellese R. Effects of Robuvit® on the progression of non-alcoholic fatty liver disease. Minerva Gastroenterol (Torino) 2022; 68:434-441. [PMID: 36507829 DOI: 10.23736/s2724-5985.22.03201-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
BACKGROUND The aim of this study was to evaluate the effects of Robuvit® in preventing the progression of chronic hepatitis (CH) in non-alcoholic fatty liver disease (NAFLD) which encompasses the entire spectrum of fatty liver disease, from isolated steatosis to non-alcoholic steatohepatitis (NASH). METHODS One group of patients followed the Standard management (SM) and were assigned as controls while the supplementation group followed the SM and additionally took 2 Robuvit® capsules daily for 3 months (200 mg/day). RESULTS 34 subjects with NAFLD were included in the study. The two groups completing 90 days were comparable at baseline with 18 being supplemented with Robuvit® and 16 in the control group. The tolerability was very good, and no side effects were observed with the supplement. Fasting glucose levels were significantly lower after 3 months with Robuvit® (P<0.05) compared to controls. The increased serum aspartate aminotransferase levels (AST), considered the key metabolic value in these patients, decreased significantly with Robuvit® (P<0.05) compared to controls. Serum alanine aminotransferase levels (ALT) also decreased significantly with the supplement compared to controls (P<0.05). Platelet count and albumin levels improved significantly with Robuvit® (P<0.05) in comparison to standard management. No other significant changes were observed. The APRI score (the AST/platelet ratio index) was also decreased with the supplementation compared to controls (P<0.05). A high APRI score provides an estimate of the possibility of the liver to develop fibrosis and eventually cirrhosis. After Robuvit® supplementation, the ultrasound characterization showed a significant decrease in the size of the liver in association with a lower echogenicity, which represents less fibrotic changes due to collagen accumulation. CONCLUSIONS Robuvit® improved liver function in NAFLD and prevented progression to liver fibrosis by improving hepatic metabolism in a relatively short period of time. Numerous people are affected by NAFLD, many of them with subclinical symptoms. But to date, there are no specific, definite treatment options. Prolonged evaluations of Robuvit® in a larger group of subjects is suggested.
Collapse
Affiliation(s)
- Gianni Belcaro
- Irvine3 Labs, San Valentino Vascular Screening Project and IA-PSS (International Agency for Pharma-Standard Supplements) Pescara, Italy -
| | - David M Cox
- Irvine3 Labs, San Valentino Vascular Screening Project and IA-PSS (International Agency for Pharma-Standard Supplements) Pescara, Italy
| | - M Rosaria Cesarone
- Irvine3 Labs, San Valentino Vascular Screening Project and IA-PSS (International Agency for Pharma-Standard Supplements) Pescara, Italy
| | - Giuseppe Gizzi
- Irvine3 Labs, San Valentino Vascular Screening Project and IA-PSS (International Agency for Pharma-Standard Supplements) Pescara, Italy
| | - Luciano Pellegrini
- Irvine3 Labs, San Valentino Vascular Screening Project and IA-PSS (International Agency for Pharma-Standard Supplements) Pescara, Italy
| | - Claudia Scipione
- Irvine3 Labs, San Valentino Vascular Screening Project and IA-PSS (International Agency for Pharma-Standard Supplements) Pescara, Italy
| | - Valeria Scipione
- Irvine3 Labs, San Valentino Vascular Screening Project and IA-PSS (International Agency for Pharma-Standard Supplements) Pescara, Italy
| | - Mark Dugall
- Irvine3 Labs, San Valentino Vascular Screening Project and IA-PSS (International Agency for Pharma-Standard Supplements) Pescara, Italy
| | - Shu Hu
- Irvine3 Labs, San Valentino Vascular Screening Project and IA-PSS (International Agency for Pharma-Standard Supplements) Pescara, Italy
| | - Marcello Corsi
- Irvine3 Labs, San Valentino Vascular Screening Project and IA-PSS (International Agency for Pharma-Standard Supplements) Pescara, Italy
| | | | - Roberto Cotellese
- Dept.SMO-Biotec, Chieti University, Italy.,Outpatients Vascular Surgery, School of General Surgery, Ch-Pe University, Pescara, Italy
| |
Collapse
|
6
|
Belcaro G, Cesarone MR, Saggino A, Dugall M, Hu S, Scipione C, Scipione V, Cornelli U, Hosoi M, Cotellese R, Cox D, Corsi M, Feragalli B. Prevention of work-related stress, fatigue, loss of cognitive function, attention and recovery of stamina with Robuvit® in professionals with increased oxidative stress. Minerva Med 2021; 113:518-525. [PMID: 34542952 DOI: 10.23736/s0026-4806.21.07776-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
AIM The aim of this open, pilot supplement registry study was to evaluate the protective, preventive effects of Robuvit® on professional-related fatigue symptoms and on aspects of cognitive functions, professional attitudes and decision-making in healthy nurses under professional stress and with increased oxidative stress. RESULTS In total, 40 subjects, aged 30 - 37, completed the 4-week registry study. A control group of 20 subjects used only the standard management (SM) and one group of 20 subjects took 300 mg Robuvit®. Safety and tolerability of Robuvit® were optimal. The two registry groups were comparable at inclusion. The overall scores of the real daily life & tasks questionnaire after 4 weeks were significantly higher in the Robuvit® group (p<0.05) as compared to controls. It increased from 4.3±0.4 at baseline to 6.78±0.8 after 4 weeks of Robuvit® intake and from 4.2±0.5 to 5.12±1.0 in the control group. The supplementation significantly improved the objective perception of fatigue in comparison with controls (p<0.05). A practical professional score evaluation provided an indication of professional attitude and stamina, in difficult, stressful working conditions under continuous pressure. The results showed that after 4-week supplementation all assessed parameters improved significantly and the difference with controls was statistically significant (p<0.05). Furthermore,oxidative stress as plasma free radicals decreased significant in the Robuvit® group (p<0.05) but not in the control group. CONCLUSIONS Robuvit® supplementation appears to improve most symptoms related to work-induced fatigue, stress and cognitive function and supports stamina. Further evaluations need to be planned according to the concept of this pilot registry in a field that requires more attention.
Collapse
Affiliation(s)
- Gianni Belcaro
- Irvine3 Labs Institute and OOLEX Research center, Pescara, Italy -
| | - Maria R Cesarone
- Irvine3 Labs Institute and OOLEX Research center, Pescara, Italy
| | - Aristide Saggino
- Psychology Faculty, D'Annunzio University, Ch - Pe University, Pescara, Italy
| | - Mark Dugall
- Irvine3 Labs Institute and OOLEX Research center, Pescara, Italy
| | - Shu Hu
- Irvine3 Labs Institute and OOLEX Research center, Pescara, Italy
| | - Claudia Scipione
- Irvine3 Labs Institute and OOLEX Research center, Pescara, Italy
| | - Valeria Scipione
- Irvine3 Labs Institute and OOLEX Research center, Pescara, Italy
| | - Umberto Cornelli
- Irvine3 Labs Institute and OOLEX Research center, Pescara, Italy
| | - Morio Hosoi
- Irvine3 Labs Institute and OOLEX Research center, Pescara, Italy
| | - Roberto Cotellese
- RADIOLOGY INSTITUTE Dpt. Sc Med or Biotec, Ch-Pe University, Pescara, Italy
| | - David Cox
- Irvine3 Labs Institute and OOLEX Research center, Pescara, Italy
| | - Marcello Corsi
- Irvine3 Labs Institute and OOLEX Research center, Pescara, Italy
| | - Beatrice Feragalli
- RADIOLOGY INSTITUTE Dpt. Sc Med or Biotec, Ch-Pe University, Pescara, Italy
| |
Collapse
|